innovation

our approach

Science and technology-driven companies typically have strong innovation capabilities. They still face challenges such as tighter budgets, stricter regulations and stakeholders who require stronger governance and transparency. Digitalization brings about new entrants in established industries. Companies need to implement more sustainable business models and leverage their innovation capabilities to create societal impact.

ELCH proposes a lean approach to uplifting a company‘s innovation management with a focus on sustainability and agility.

We thereby focus on the six elements of any innovation system

This leads to tangible results after 90 days and sets the foundation for smooth scale-up

Whilst building and advancing innovation systems in various industries, ELCH has a team of specialists with a particular focus on pharma R&D

what

Pharmaceutical R&D is facing change driven by regulators, payers, patients, competitors, new (tech) entrants
Drug programs and pipelines increasingly require a combination of scientific, clinical, regulatory, tech and business know-how at the same time to master evolving environments

how

Assessment of as-is situation and definition of to-be state
Strategy design and implementation
Process management
Change management
Individual drug programs
Project management
Support of specific (trial) deliverables

impact

Meet regulatory and compliance requirements
Improved R&D productivity
Ensure competitiveness by creating innovative healthcare solutions
Enable delivery at the level of individual drug programs and projects, minimizing risks and accelerating timelines